VMBIP Newsletter – July 25, 2008
Please scroll past the charts for VMBIP updates.
McKesson Performance Dashboard 
CDC Weekly Performance Metric Scorecard

A.
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending July 4, 2008: 86.4 percent
Week Ending July 11, 2008:  91.0 percent
Week Ending July 18, 2008:   96.5 percent
Weighted Average Last 3 Weeks:  91.9 percent
Explanation:  None

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders
Week Ending July 4, 2008:  97 percent
Week Ending July 11, 2008:  98.8 percent
Week Ending July 18, 2008:   100 percent
Weighted Average Last 3 Weeks:  99.1 percent
Explanation:  none

C1
Metric: 99 percent Order Quality (McKesson Responsibility)
Week Ending July 4, 2008:  100 percent
Week Ending July 11, 2008:  100 percent
Week Ending July 18, 2008:  100  percent
Weighted Average Last 3 Weeks:  100 percent  
Explanation:  none

C2
Metric: 99 percent Order Quality (All Responsibility – all error types)
Week Ending July 4, 2008:  98.75 percent
Week Ending July 11, 2008:  99.95 percent
Week Ending July 18, 2008:  98.62 percent
Weighted Average Last 3 Weeks:  99.14 percent
Explanation:  none

D
Metric: 99.75 percent – Cold Chain Quality
Week Ending July 4, 2008:  100 percent
Week Ending July 11, 2008:  100 percent
Week Ending July 18, 2008:  100 percent
Weighted Average Last 3 Weeks:  100 percent
Explanation:  none

E
Metric: Vaccine Receipt and Put Away and CDC Transmission
Week Ending July 4, 2008:  100 percent
Week Ending July 11, 2008:  100 percent
Week Ending July 18, 2008:  100 percent
Weighted Average Last 3 Weeks:  100 percent
Explanation:  None

F
Metric: State Funded PO Transmission
Week Ending July 4, 2008:  100 percent
Week Ending July 11, 2008:  *94 percent
Week Ending July 18, 2008:  91 percent
Weighted Average Last 3 Weeks:  94 percent
Explanation:  *Last week the listed exceptions were excluded from the metric and reported as 100%.  This was corrected and is now showing the correct %.
7/11: Two receipts were not received in time due to grantee/CDC hold on the product received
7/18: One receipt arrived without paperwork identifying the owner (grantee) of the product, research took multiple days to complete

A.   percent of provider orders shipped within 3 days of McKesson receiving order from CDC; removes all orders which include an allocated vaccine, and all lines of product on backorder  - an order is defined as all vaccines requested by a provider on a given day; a line (order line) is defined as the individual vaccines that make up the order		 
B.    percent of provider orders shipped within 5 days of McKesson receiving order from CDC; removes all orders which include an allocated vaccine, and all lines of product on backorder	
C1.   percent of provider orders delivered with viable vaccine; excludes errors that aren't McKesson's responsibility – Return Reasons: Temp Monitor, non-compliant pack-out, mis-ship, undeliverable or customer not available, or carrier damage
C2.    percent of provider orders delivered with viable vaccine; includes all errors for both CDC and McKesson: Return Reasons: see C1 for McKesson responsibility reasons and incorrect address and delivery info, site damaged, expired product, product recall, and other are CDC’s responsibility 
D.    percent of provider orders delivered with cold chain maintained – Return Reason: Temp Monitor	
E.    percent of CDC replenishment orders McKesson receives into inventory, receives into IT system, and transmits to CDC within 24 (flu) and 48 (other) hrs of delivery by manufacturer
F.    percent of grantee replenishment orders McKesson faxes and e-mails receipt of to grantees within 48 hrs of delivery by manufacturer

Vaccines on Allocation HEPB-HIB, HIB (PedvaxHIB and ActHIB) and FLU;  Manufacture Shortage (Merck Hep A)
Vaccines placed on backorder during the most recent week:  DTAP-HIB (490 doses) – incorrectly ordered by grantee; Hep A (60 doses) – vaccine on manufacturer shortage  - incorrectly ordered by grantee; Hep AB (180 doses) – orders placed, still waiting on inventory; Hep B-Adult (25 doses) – orders placed, still waiting on inventory; TD (765 doses) – orders placed, still waiting on inventory; TDAP (150 doses) – orders placed, still waiting on inventory 

McKesson Performance Dashboard – Shipping Metrics by Distribution Center
CDC Weekly Performance Metric Scorecard

Memphis (8578)
A
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending July 4, 2008:  86.7 percent
Week Ending July 11, 2008:  88.6 percent
Week Ending July 18, 2008:  96.4 percent
Weighted Average Last 3 Weeks:  91.4 percent
Explanation:  none

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders
Week Ending July 4, 2008:  95.4 percent
Week Ending July 11, 2008:  99.9 percent
Week Ending July 18, 2008:  100 percent
Weighted Average Last 3 Weeks:  98.9 percent
Explanation:  none

Sacramento (8576)
A
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending July 4, 2008:  85.7 percent
Week Ending July 11, 2008:  93.8 percent
Week Ending July 18, 2008:  96.7 percent
Weighted Average Last 3 Weeks:  93.3 percent
Explanation:  none

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders
Week Ending July 4, 2008:  99.6 percent
Week Ending July 11, 2008:  99.7 percent
Week Ending July 18, 2008:  99.9 percent
Weighted Average Last 3 Weeks: 99.7 percent
Explanation:  none
 
A.   percent of provider orders shipped within 3 days of McKesson receiving order from CDC; removes all orders which include an allocated vaccine, and all lines of product on backorder – an order is defined as all vaccines requested by a provider on a given day; a line (order line) is defined as the individual vaccines that make up the order
B.   percent of provider orders shipped within 5 days of McKesson receiving order from CDC; removes all orders which include an allocated vaccine, and all lines of product on backorder

VMBIP Updates
•	As mentioned during the July 24 AIM general membership call, CDC is finalizing a flu guidance document that will be distributed to you via an all-grantee message early next week.  The document will provide you with critical information about the upcoming influenza vaccine ordering and distribution processes and assist you in planning for and managing your project area’s influenza vaccination program.  It is imperative that you read the document thoroughly.  There will be an all-grantee conference call approximately one week after we distribute the document to address your questions. 

•	During the Vaccine University centralized distribution plenary session, we announced that a grantee-tailored “Reports Inventory” was under development.  Attached is the finalized document which we have expanded to include all VMBIP-related, grantee-specific, proactive outbound notifications distributed by CDC and McKesson.  To capture its expanded scope, we have changed its name accordingly to “Inventory of Proactive Notifications to Grantees.”  The document is current as of July 11.  We will forward you updated versions when applicable.  If you have any questions, please email Julie Orta jio7@cdc.gov and cc your POB project officer. 

•	Earlier this month, McKesson implemented an allocation system in its SAP software.  Under this new system, any Hib doses that you order in excess of your monthly Hib allocation are placed in backorder status, and therefore those doses appear on your daily backorder report even though there actually are doses in inventory at the Memphis and Sacramento distribution centers.  

•	The VTrckS Grantee Advisory Committee (GAC) is in place.  Members were solicited from the grantee population with recommendations from AIM and AIRA leadership. The GAC has ongoing teleconference meetings every other week and is scheduled to meet in Atlanta on September 9 and 10 to participate in a review of the latest VMBIP to-be business model materials and a prototype demonstration.  If you have specific suggestions, please contact any GAC member to bring these issues forward.  A list of members and their contact information is on the VMBIP website, VTrckS webpage. 

As a reminder, VMBIP related all-grantee messages are posted to the VMBIP website at: http//www.cdc.gov/vaccines/programs/vmbip/documents.htm and previous newsletters are posted at http//www.cdc.gov/vaccines/programs/vmbip/newsletters.htm 

If you have any questions or comments about the contents of this email, please contact Brad Prescott bap3@cdc.gov or Julie Orta jio7@cdc.gov, with a cc to your project officer. 

Brad Prescott
Project Lead
Vaccine Management Business Improvement Project 
Immunization Services Division 
Centers for Disease Control and Prevention
404-639-8796 (direct)
404-639-8627 (fax)
bap3@cdc.gov 

This document can be found on the CDC website at:
http://www.cdc.gov/vaccines/programs/vmbip/downloads/newsletters/vmbip-nl-07-25-08.rtf